Brand A, Vissiennon Z, Eschke D, Nieber K
Department of Pharmacy, University of Leipzig, Brüderstrasse 34, D-04103, Leipzig, Germany.
Neuropharmacology. 2001;40(1):85-95. doi: 10.1016/s0028-3908(00)00117-9.
Intracellular recordings were made in rat brain slice preparations containing pyramidal cells of the associative frontal cortex in order to characterize the action of selective adenosine A(1) and A(3) receptor ligands on synaptic neurotransmission. The selective A(1) receptor agonist N(6)-cyclopentyladenosine (CPA) inhibited concentration-dependently the excitatory postsynaptic potentials (PSPs) which were evoked by focal electrical stimulation. The CPA-mediated inhibition was blocked by 1, 3-dipropyl-8-cyclopentylxanthine (DPCPX), a highly A(1) receptor-selective antagonist. The A(3) receptor agonist N(6)-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide (IB-MECA) inhibited concentration-dependently the evoked PSPs while the A(1) receptors were blocked continuously by DPCPX. Under these conditions, the A(3) receptor antagonist 9-chloro-2-(2-furanyl)-5-[(phenylacetyl)amino]-1,2,4-triazolo[1, 5-c]quinazoline (MRS 1220) did not influence the PSPs but inhibited completely the effect of IB-MECA. The inhibitory effect of IB-MECA was unaffected by DPCPX. CPA additionally inhibited the PSPs when applied after IB-MECA. Pharmacological dissociation of the N-methyl-D-aspartate (NMDA) and non-NMDA receptor components of the PSPs showed that CPA as well as IB-MECA reduced both. We conclude that adenosine A(1) and A(3) receptors are present on cortical pyramidal cells and involved in the inhibition of excitatory neurotransmission. Our results indicate no interplay between the two receptor subtypes. The separate inhibition may become particularly evident in situations where there are high levels of endogenously released adenosine, as seen in hypoxia.
为了描述选择性腺苷A(1)和A(3)受体配体对突触神经传递的作用,在含有联合额叶皮质锥体细胞的大鼠脑片标本中进行了细胞内记录。选择性A(1)受体激动剂N(6)-环戊基腺苷(CPA)浓度依赖性地抑制局灶性电刺激诱发的兴奋性突触后电位(PSP)。CPA介导的抑制作用被1,3-二丙基-8-环戊基黄嘌呤(DPCPX)阻断,DPCPX是一种高度选择性的A(1)受体拮抗剂。A(3)受体激动剂N(6)-(3-碘苄基)-腺苷-5'-N-甲基甲酰胺(IB-MECA)浓度依赖性地抑制诱发的PSP,而A(1)受体被DPCPX持续阻断。在这些条件下,A(3)受体拮抗剂9-氯-2-(2-呋喃基)-5-[(苯乙酰基)氨基]-1,2,4-三唑并[1,5-c]喹唑啉(MRS 1220)不影响PSP,但完全抑制IB-MECA的作用。IB-MECA的抑制作用不受DPCPX影响。在IB-MECA之后应用时,CPA也抑制PSP。PSP的N-甲基-D-天冬氨酸(NMDA)和非NMDA受体成分的药理学解离表明,CPA和IB-MECA都降低了两者。我们得出结论,腺苷A(1)和A(3)受体存在于皮质锥体细胞上,并参与抑制兴奋性神经传递。我们的结果表明这两种受体亚型之间没有相互作用。在缺氧等内源性腺苷释放水平较高的情况下,这种单独的抑制作用可能会变得尤为明显。